How 5 health systems are avoiding a repeat of the 2023 chemo shortage

Chemotherapy drugs like cisplatin, carboplatin, oxaliplatin, and ifosfamide are once again in short supply, echoing the issues faced last year. However, five health systems are successfully navigating this crisis without the delays and rationing seen in 2023. These systems are employing innovative strategies to maintain their supply chains, ensuring they can continue to provide essential cancer treatments to patients. This proactive approach is crucial, given the significant strain these shortages place on hospital resources and patient care.